A
Ana-Catarina Pinho-Gomes
Researcher at King's College London
Publications - 58
Citations - 1268
Ana-Catarina Pinho-Gomes is an academic researcher from King's College London. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 11, co-authored 39 publications receiving 496 citations. Previous affiliations of Ana-Catarina Pinho-Gomes include St George's Hospital & The George Institute for Global Health.
Papers
More filters
Journal ArticleDOI
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Kazem Rahimi,Zeinab Bidel,Milad Nazarzadeh,Emma Copland,Dexter Canoy,Rema Ramakrishnan,Ana-Catarina Pinho-Gomes,Mark Woodward,Amanda I Adler,Larry Agodoa,Ale Algra,Folkert W. Asselbergs,Nigel S Beckett,Eivind Berge,Henry R. Black,Frank P. Brouwers,Morris J. Brown,Christopher J. Bulpitt,Robert P Byington,William C. Cushman,Jeffrey Cutler,Richard B Devereaux,Jamie P. Dwyer,Ray Estacio,Robert Fagard,Kim Fox,Tsuguya Fukui,Ajay Gupta,Rury R. Holman,Yutaka Imai,Masao Ishii,Stevo Julius,Yoshihiko Kanno,Sverre E. Kjeldsen,John B. Kostis,Kizuku Kuramoto,Jan Lanke,Edmund J. Lewis,Julia B Lewis,Michel Lievre,Lars H Lindholm,Stephan Lueders,Stephen MacMahon,Giuseppe Mancia,Masunori Matsuzaki,Maria H Mehlum,Steven E. Nissen,Hiroshi Ogawa,Toshio Ogihara,Takayoshi Ohkubo,Christopher R. Palmer,Anushka Patel,MA Pfeffer,Bertram Pitt,Neil R Poulter,Hiromi Rakugi,Gianpaolo Reboldi,Christopher M. Reid,Giuseppe Remuzzi,Piero Ruggenenti,Takao Saruta,Joachim Schrader,Robert W. Schrier,Peter S. Sever,Peter Sleight,Jan A. Staessen,Hiromichi Suzuki,Lutgarde Thijs,Kenji Ueshima,Seiji Umemoto,Wiek H. van Gilst,Paolo Verdecchia,Kristian Wachtell,Paul K. Whelton,Lindon Wing,Yoshiki Yui,Salim Yusuf,Alberto Zanchetti,Zhen-Yu Zhang,Craig S. Anderson,Colin Baigent,Barry M. Brenner,Rory Collins,Dick de Zeeuw,Jacobus Lubsen,Ettore Malacco,Bruce Neal,Vlado Perkovic,Anthony Rodgers,Peter M. Rothwell,Gholamreza Salimi-Khorshidi,Johan Sundström,Fiona Turnbull,Giancarlo Viberti,Ji-Guang Wang,John Chalmers,Koon K. Teo,Carl J. Pepine,Barry R. Davis +98 more
TL;DR: In this paper, a meta-analysis of individual participant-level data from 48 randomised trials of pharmacological blood pressure lowering medications versus placebo or other classes of blood pressure-lowering medications, or between more versus less intensive treatment regimens, was performed.
Journal ArticleDOI
Where are the women? Gender inequalities in COVID-19 research authorship.
Ana-Catarina Pinho-Gomes,Sanne A.E. Peters,Sanne A.E. Peters,Kelly Thompson,Carinna Hockham,Katherine Ripullone,Mark Woodward,Mark Woodward,Cheryl Carcel +8 more
TL;DR: Investigating whether gender differences existed in authorship of COVID-19 research since the onset of the pandemic found that women’s representation in research generally and specifically in the study of CO VID-19 may be disproportionately affected by lockdown measures.
Journal ArticleDOI
Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials
Ana-Catarina Pinho-Gomes,Luís Filipe Azevedo,Jung-Min Ahn,Seung-Jung Park,Taye H. Hamza,Michael E. Farkouh,Patrick W. Serruys,Milan Milojevic,Arie Pieter Kappetein,Gregg W. Stone,Andre Lamy,Valentin Fuster,David P. Taggart +12 more
TL;DR: Compliance with GDMT in contemporary clinical trials remains suboptimal and is significantly lower after CABG than after PCI, which may influence the comparison of clinical trial endpoints between those study groups.
Journal ArticleDOI
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals
Nathalie Conrad,Andrew Judge,Andrew Judge,Andrew Judge,Dexter Canoy,Jenny Tran,Jenny Tran,Ana-Catarina Pinho-Gomes,Ana-Catarina Pinho-Gomes,Elizabeth R C Millett,Gholamreza Salimi-Khorshidi,Gholamreza Salimi-Khorshidi,John G.F. Cleland,John J.V. McMurray,Kazem Rahimi +14 more
TL;DR: Management strategies that solely target cardiovascular outcomes appear insufficient to improve the survival of patients with heart failure; the management of associated comorbidities, particularly infection prevention, appears as a major priority and opportunity.
Journal ArticleDOI
Targeting Inflammation and Oxidative Stress in Atrial Fibrillation: Role of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibition with Statins
TL;DR: Evidence indicates that statins prevent AF-induced electrical remodeling in animal models of atrial tachypacing and may reduce the new onset of AF after cardiac surgery.